Back
Establishment Labs Holdings, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Buy
52
ESTA
Establishment Labs Holdings, Inc.
Last Price:
$68.43
Seasonality Move:
15.55%
Sell
39
MNPR
Monopar Therapeutics, Inc.
Last Price:
$62.76
Seasonality Move:
-12.16%
Buy
52
Establishment Labs Holdings, Inc. (ESTA)
is a Buy
Is Establishment Labs Holdings, Inc. a Buy, Sell or Hold?
-
The current Establishment Labs Holdings, Inc. [ESTA] share price is $68.34. The Score for ESTA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
ESTA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $63.00. The Score for MNPR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ESTA Stock Price Chart
What is Establishment Labs Holdings, Inc.'s stock price today?
-
The Establishment Labs Holdings, Inc. share price today is $68.34The current trend is moderately bearish and ESTA is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $63.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
ESTA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 46.11 | Sell |
| Chaikin Money Flow: | -506774 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.52 - 74.84) | Sell |
| Bollinger Bands (100): | (40.36 - 68.56) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.18 | Sell |
| Relative Strength Index (14 RSI): | 36.87 | Sell |
| Chaikin Money Flow: | -152016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.55 - 76.15) | Sell |
| Bollinger Bands (100): | (51.85 - 89.73) | Sell |
ESTA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 70.72 | Sell |
| 20-day SMA: | 72.66 | Sell |
| 50-day SMA: | 67.32 | Buy |
| 200-day SMA: | 45.96 | Buy |
| 8-day EMA: | 70.86 | Sell |
| 20-day EMA: | 71.21 | Sell |
| 50-day EMA: | 66.28 | Buy |
| 200-day EMA: | 51.31 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.77 | Sell |
| 20-day SMA: | 68.5 | Sell |
| 50-day SMA: | 76.96 | Sell |
| 200-day SMA: | 54.25 | Buy |
| 8-day EMA: | 64.39 | Sell |
| 20-day EMA: | 68.28 | Sell |
| 50-day EMA: | 72.5 | Sell |
| 200-day EMA: | 57.72 | Buy |
Establishment Labs Holdings, Inc. Earnings Growth & ESTA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and an increase next year of $1.31 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.78 per share, and a decrease next year of $0.34 per share.
Establishment Labs Holdings, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||